Donjetë Simnica
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 4
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
-
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5
- Colorectal Cancer Treatments and Studies 2
-
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Mascha BinderChristoph SchultheißEdith WillscherLisa PascholdLorenzo F. FanchiSimon SchliffkeLisa von WenserskiNuray Akyüz
- Journals
- Frontiers in Immunology (2 papers)Journal of Clinical Investigation (2 papers)Haematologica (2 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Donjetë Simnica
20 papers receiving 401 citations
Peers
Comparison fields: 5 of 52
- Infectious Diseases 122
- Immunology 123
- Oncology 129
- Hepatology 30
- Pathology and Forensic Medicine 58
Countries citing papers authored by Donjetë Simnica
This map shows the geographic impact of Donjetë Simnica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donjetë Simnica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donjetë Simnica more than expected).
Fields of papers citing papers by Donjetë Simnica
This network shows the impact of papers produced by Donjetë Simnica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donjetë Simnica. The network helps show where Donjetë Simnica may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donjetë Simnica, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 13 | |
| 2 | 2022 | 16 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 9 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 99 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 26 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 28 | |
| 15 | 2020 | 28 | |
| 16 | 2020 | 8 | |
| 17 | 2020 | 42 | |
| 18 | 2019 | 7 | |
| 19 | 2019 | 16 | |
| 20 | 2019 | 43 |
About Donjetë Simnica
Donjetë Simnica is a scholar working on Genetics, Immunology, Oncology, Infectious Diseases and Hematology, having authored 20 papers that have together received 402 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), CAR-T cell therapy research (5 papers), COVID-19 Clinical Research Studies (4 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Infectious Diseases (122 citations), Immunology (123 citations), Oncology (129 citations), Hepatology (30 citations) and Pathology and Forensic Medicine (58 citations). Donjetë Simnica has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Mascha Binder, Christoph Schultheiß, Edith Willscher, Lisa Paschold, Lorenzo F. Fanchi, Simon Schliffke, Lisa von Wenserski, Nuray Akyüz, Chintda Santiskulvong and Harsha Chandnani. Their work appears in journals such as Frontiers in Immunology, Journal of Clinical Investigation, Haematologica, Frontiers in Oncology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.